These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10233813)

  • 1. Trichophyton tonsurans as a cause of onychomycosis.
    Nenoff P; Gebauer S; Wolf T; Haustein UF
    Br J Dermatol; 1999 Mar; 140(3):555-7. PubMed ID: 10233813
    [No Abstract]   [Full Text] [Related]  

  • 2. White superficial onychomycosis of the fingernail caused by Trichophyton rubrum in an immunocompetent patient.
    Kornbleuth S; Hsu S
    Cutis; 1999 Aug; 64(2):99-100. PubMed ID: 10467501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal melanonychia caused by Trichophyton rubrum and the value of dermoscopy.
    Wang YJ; Sun PL
    Cutis; 2014 Sep; 94(3):E5-6. PubMed ID: 25279488
    [No Abstract]   [Full Text] [Related]  

  • 4. Onychomycosis. New therapies for an old disease.
    Gupta AK; Scher RK; De Doncker P; Sauder DN; Shear NH
    West J Med; 1996 Dec; 165(6):349-51. PubMed ID: 9000854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission of two feet-one hand syndrome.
    Seeburger J; Scher RK
    Cutis; 1998 Mar; 61(3):149-51. PubMed ID: 9538957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole: an effective oral antifungal for onychomycosis.
    Jain S; Sehgal VN
    Int J Dermatol; 2001 Jan; 40(1):1-5. PubMed ID: 11277944
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population.
    Wang DL; Wang AP; Li RY; Wang R
    Dermatology; 1999; 199(1):47-9. PubMed ID: 10449957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
    Tosti A; Piraccini BM; Stinchi C; Colombo MD
    Dermatology; 1998; 197(2):162-6. PubMed ID: 9732167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of classic Kaposi sarcoma with Trichophyton rubrum-infected onychomycosis and tinea pedis utilizing combination of oral itraconazole and thalidomide.
    Chen J; Zheng Y; Zhu C; Lin L; Su H
    J Dermatol; 2024 May; 51(5):727-730. PubMed ID: 38087640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.
    Eba M; Njunda AL; Mouliom RN; Kwenti ET; Fuh AN; Nchanji GT; Atashili J
    BMC Res Notes; 2016 Nov; 9(1):494. PubMed ID: 27876085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
    Ranawaka RR; de Silva N; Ragunathan RW
    J Dermatolog Treat; 2008; 19(5):308-12. PubMed ID: 19160539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycotic pseudoleuconychia affecting the fingernails.
    Rathore T; Millington GW
    Clin Exp Dermatol; 2010 Jul; 35(5):558-9. PubMed ID: 20184612
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral terbinafine and itraconazole treatments against dermatophytes appear not to favor the establishment of Fusarium spp. in nail.
    Verrier J; Bontems O; Baudraz-Rosselet F; Monod M
    Dermatology; 2014; 228(3):225-32. PubMed ID: 24603371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
    Bradley MC; Leidich S; Isham N; Elewski BE; Ghannoum MA
    Mycoses; 1999; 42 Suppl 2():105-10. PubMed ID: 10865915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONMEL (itraconazole) 200-mg tablet.
    Gupta AK; Paquet M; Abramovits W
    Skinmed; 2013; 11(2):105-7. PubMed ID: 23745229
    [No Abstract]   [Full Text] [Related]  

  • 18. Endonyx onychomycosis caused by Trichophyton tonsurans.
    Bunyaratavej S; Bunyaratavej S; Muanprasart C; Matthapan L; Varothai S; Tangjaturonrusamee C; Pattanaprichakul P
    Indian J Dermatol Venereol Leprol; 2015; 81(4):390-2. PubMed ID: 25994895
    [No Abstract]   [Full Text] [Related]  

  • 19. The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen.
    Piérard GE; Piérard-Franchimont C; Arrese JE
    Dermatology; 2000; 200(2):185-7. PubMed ID: 10773718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing and treating onychomycosis.
    Zaias N; Glick B; Rebell G
    J Fam Pract; 1996 May; 42(5):513-8. PubMed ID: 8642370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.